Jenny Robertson's Stock Sale and Vesting at Lexeo Therapeutics

Jenny Robertson, an officer at Lexeo Therapeutics, Inc., has reported the sale and vesting of common stock. On October 15, 2025, Robertson vested 3,526 shares of restricted stock as part of her compensation. These shares were acquired from the issuer. Additionally, Robertson sold 542 shares on August 18, 2025, generating gross proceeds of $2,530.16. The sale included an amount necessary to cover a tax obligation resulting from the settlement of the vested equity award distribution. The securities are traded on NASDAQ, and the transactions were facilitated by Fidelity Brokerage Services LLC. As of the notice date, October 17, 2025, Robertson holds 54,001,214 shares of common stock in Lexeo Therapeutics.